Study of Pomegranate Juice in the Modulation of Oxidative Stress Markers in Endurance-based Athletes
NCT ID: NCT02293486
Last Updated: 2014-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
20 participants
INTERVENTIONAL
2012-08-31
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Arm that followed all the protocols with the exception of the pomegranate juice intake.
No interventions assigned to this group
Pomegranate Juice
Arm that followed all the protocols and the pomegranate juice intake.
Pomegranate juice
Intake of 200 ml of pomegranate juice or pomegranate juice dilution during 21 days after exercise.
Pomegranate Juice Dilution
Arm that followed all the protocols and the pomegranate juice dilution (1:1) intake.
Pomegranate juice
Intake of 200 ml of pomegranate juice or pomegranate juice dilution during 21 days after exercise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pomegranate juice
Intake of 200 ml of pomegranate juice or pomegranate juice dilution during 21 days after exercise.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* More than 1 hour per session and more than 3 sessions per week
* Have participated recently in a half marathon or similar event
Exclusion Criteria
* Present a chronic disorder
* Non-smoker
* No-alcoholic beverage consumption
18 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vitalgrana Pomegranate SL
UNKNOWN
Universidad Miguel Hernandez de Elche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Néstor Vicente-Salar
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Enrique Roche, PhD
Role: STUDY_DIRECTOR
University Miguel Hernández
References
Explore related publications, articles, or registry entries linked to this study.
Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 2000 May;71(5):1062-76. doi: 10.1093/ajcn/71.5.1062.
Trombold JR, Reinfeld AS, Casler JR, Coyle EF. The effect of pomegranate juice supplementation on strength and soreness after eccentric exercise. J Strength Cond Res. 2011 Jul;25(7):1782-8. doi: 10.1519/JSC.0b013e318220d992.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GRA 01
Identifier Type: -
Identifier Source: org_study_id